[1] |
YOU Rongli, HUANG Yurong, MAORui, HAI Lina, WANG Yingli, WANG Yan.
Mechanism of compound kushen injection in the treatment of lung cancer based on serum metabolomics and network pharmacology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 988-999.
|
[2] |
FAN Jie, JIN Yongming, JIANG Xiaolong, JIANG Guohua.
Molecular mechanism of lncRNA HOTAIR regulating miR-206 on the proliferation and apoptosis of rheumatoid arthritis synovial cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 736-742.
|
[3] |
LI Ruoning, GUO Zhanli, WANG Yuan, SUN Jianjun.
Platelet-endothelial aggregation receptor 1 and its mediated signalling pathway Advances in the study of the role of platelets and endothelial cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 438-444.
|
[4] |
CAO Fang, QIN Kairong, ZHENG Guoshuang, ZHAO Dewei.
Exploring the intervention mechanism of Ginkgo biloba for steroid-induced necrosis of the femoral head based on network pharmacology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 266-275.
|
[5] |
MA Guangli, ZHANG Jing.
Application of quantitative pharmacology in vaccine research and de-velopment: overview and prospect
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 315-322.
|
[6] |
HOU Xiaoyu, LENG Yufang, CAO Xuefen, LV Xingjiao, HAN Xiaoxia, Janvier NIBARUTA, LIU Yongqiang.
Network analysis and experimental verification of Schisandrin B reduces intestinal ischemia reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 147-154.
|
[7] |
WANG Jian, SUN Yongdong, ZHOU Xingwei, LIU Lei, CHEN Long, TONG Xingke, ZHU Jiali.
Baicalein promotes laryngeal cancer cell death and inhibits invasion via miR-125b-5p/IRF4 axis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1209-1218.
|
[8] |
LIU Lu, SHI Yufei, HE Qingfeng, XU Fengyan, WANG Kun, CAI Weimin, XIANG Xiaoqiang.
Application of population modeling analysis to evaluate the impact of gene polymorphism on drug PK/PD
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1275-1282.
|
[9] |
CHEN Yulin, JIANG Hugang, WANG Xinqiang, LIU Kai, LI Yingdong, AN Tao, ZHAO Xinke.
Effects and mechanism of Ginseng Yixin granules (QSYXG) for heart failure with preserved ejection fraction based on the network pharmacology and molecular docking strategy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1081-1092.
|
[10] |
HENG Bingbing, YANG Danfeng, DAI Shuyang, SHANGGUAN Wangning.
Propofol relieves the subcutaneous chloroquine-induced pruritus in rats via TRPV1 and CB1 receptors of spinal cord
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1101-1108.
|
[11] |
ZHENG Hongbo , YAO Wenlong , LUO Ailin, ZHOU Biyun.
Application of remimazolam combined with propofol in painless endoscopic retrograde cholangiopancreatography
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1154-1160.
|
[12] |
LIU Jiajun, QUE Zujun, TIAN Jianhui.
Comparative study on the ability of active ingredients in Jinfukang to decrease neutrophils recruiting by lung cancer circulating tumor cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 1-9.
|
[13] |
HUANG Hao, JIA Hong, WANG Xiaoshuang, ZHANG Lu, JIANG Hua.
Effects of co-culture of dendritic cells loaded with MAGE-A3 antigen and cytokine-induced killer cells on tumor stem cells and malignant progression of endometrial cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 42-50.
|
[14] |
GAO Lili, WANG Yuzhu, WANG Yan, LI Jian, WANG Jun.
General considerations for clinical pharmacology of antitumor antibody-conjugated drugs: Implications from FDA review cases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 75-85.
|
[15] |
SHEN Chang, AI Kelong, HU Changping.
Research progress in the regulation of hypoxic pulmonary hypertension by hypoxia-inducible factor-1 signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 114-120.
|